Skip to main content
Year archive

CKD Bio Corp. — 2025 filings

All 16 regulatory filings released by CKD Bio Corp. (063160) in 2025, sourced directly from the official regulator.

16 Filings
2025 Period
2025 filings (16)
Filing Released Lang
영업(잠정)실적(공정공시)
Regulatory Filings
2025-10-31 Korean
투자판단관련주요경영사항
Regulatory Filings
2025-09-17 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
영업(잠정)실적(공정공시)
Earnings Release H1 2025
2025-07-25 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
영업(잠정)실적(공정공시)
Earnings Release Q1 2025
2025-04-25 Korean
투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청)
Regulatory Filings
2025-04-09 Korean
투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인)
Regulatory Filings
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-26 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-18 Korean
사업보고서 (2024.12)
Annual Report FY 2024
2025-03-18 Korean
주주총회소집결의
AGM Information
2025-02-25 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2025-02-25 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2024
2025-01-24 Korean